VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 168 filers reported holding VIKING THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,186,325 | -34.5% | 197,500 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $3,339,260 | +20.2% | 206,000 | +23.4% | 0.00% | 0.0% |
| Q1 2023 | $2,778,885 | +455.8% | 166,900 | +0.2% | 0.00% | – |
| Q1 2022 | $500,000 | -30.0% | 166,500 | +7.2% | 0.00% | – |
| Q4 2021 | $714,000 | -26.8% | 155,300 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $975,000 | +12.1% | 155,300 | +7.0% | 0.00% | 0.0% |
| Q2 2021 | $870,000 | -8.3% | 145,200 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $949,000 | +14.6% | 150,000 | +2.0% | 0.00% | 0.0% |
| Q4 2020 | $828,000 | -3.3% | 147,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $856,000 | -19.2% | 147,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,060,000 | +82.1% | 147,000 | +18.2% | 0.00% | 0.0% |
| Q1 2020 | $582,000 | -41.7% | 124,400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $998,000 | +21.3% | 124,400 | +4.0% | 0.00% | 0.0% |
| Q3 2019 | $823,000 | -17.1% | 119,600 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $993,000 | -14.8% | 119,600 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $1,165,000 | +36.4% | 117,200 | +5.0% | 0.00% | 0.0% |
| Q4 2018 | $854,000 | – | 111,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |